Cataract & Refractive Surgery: Princess Margaret Hospital

Total Score People Score Events Score
38 35 6
Date Event Presentation Speakers
July 5, 2016 The 3rd Friends of Israel Urology Symposium (FOIU) TULSA: in bore transurethral US ablation Laurence H Klotz
The 3rd Friends of Israel Urology Symposium (FOIU) Neil Fleshner
No: Laurence Klotz, Canada Laurence H Klotz
The role of statins and metformins in preventing disease progression Neil Fleshner
Session 20 | Prostate Cancer Laurence H Klotz
February 24, 2011 Fourth Annual International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery Volumetric Modulated Arc Therapy for Extracranial SBRT Daniel Letourneau
Implementing Lung SBRT Program Andrea Bezjak
September 3, 2010 Fourth Asian Pacific Conference: Perspectives in Lung Cancer Clinical trial on molecular targeting agent: What is right and what is wrong? Frances Shepherd
July 29, 2010 Neurosurgery Update 2010 in the Wine Country Repair and Regeneration of the Injured Spinal Cord – What is New on the Horizon? Michael G Fehlings
New Concepts in the Pathophysiology and Treatment of Cervical Spondylotic Myelopathy Michael G Fehlings
November 15, 2007 The Joint Meeting of the 4th ISC International Conference on Cancer Therapeutics and The 7th Princess Margaret Hospital Conference: New Developments in Cancer Management Welcome from PMH Mary K. Gospodarowicz
Welcome from ISC Ronald Feld
Predictive biomarkers in targeted therapy: Lessons learned Ming-Sound Tsao
Session I: Targeted Therapies I Ming-Sound Tsao
Going beneath the surface: Novel agents for downstream signaling targets David W. Hedley
Targeted therapies for CNS malignancies Warren P. Mason
Surgical debate: Is there a role for surgery in stage IIIA NSCLC? Gail E. Darling
Session III: Gastrointestinal malignancies Eric X. Chen
Targeted therapy of pancreas Malcolm J Moore
Liver radiotherapy Laura A. Dawson
Welcome to day two Ronald Feld
PET/CT for GI tumors Ur Metser
Session V: Genitourinary Neil Fleshner, Srikala Sridhar
Image guided therapy in prostate cancer John Trachtenberg
Targeted radiotherapy in urologic cancer Cynthia Ménard
Session VI: Targeted Therapies II Mary K. Gospodarowicz
Measuring residual DNA damage in situ as a clinical biomarker of molecular target inhibition in radiotherapy and chemotherapy trials Robert G Bristow
Challenges in the design of early phase clinical trials evaluating combinations of radiotherapy and molecularly targeted therapies Anthony Brade
Session VII: Malignant Hematology Michael Crump, Hans A. Messner
Update on chelation therapy Karen W.L. Yee
Management of patients with CML: Beyond imatinib Jeffrey H. Lipton
Management of the elderly with acute myeloid leukemia Joseph Brandwein
Targeted therapy for lymphoma Michael Crump
Targeted therapy in the elderly Lillian L. Siu
Welcome to day three Ronald Feld
Pharmacogenomic markers in lung cancer Geoffrey Liu
Session X: Breast Cancer Natasha Leighl, David Warr
Targeted therapy: Targeting tumors or targeting patients? Christine Simmons
Session XI: Supportive Care: Managing Toxicities of Targeted Agents Janice Wright
Safety and efficacy of rituximab abbreviated infusion Tracy Nagy
Session XII: Challenging Cases Ronald Feld, Joseph Mikhael
Bladder cancer: Adjuvant versus neoadjuvant therapies Srikala Sridhar
Lymphoma: Maintenance therapy Vishal Kukreti
Locally advanced lung cancer: Combined modality therapy Andrea Bezjak, Natasha Leighl
October 27, 2007 Current Trends in Genitourinary Malignancies Focal Therapy, Targeted Therapy, and Partial Prostatectomy John Trachtenberg
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.